Ipsen Pharma Biotech
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- France
- Registered address
- PARC D'ACTIVITE DE SIGNES CHE DEPARTEMENTAL 402, SIGNES, PROVENCE ALPES COTE D'AZUR 83870, France (FRA)
- Operations here
- analysislabelmanufacturepack
- FDA identifiers
- FEI 3003749112 · DUNS 502570286
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2024-03-29
- VAIDrug Quality Assurance2020-11-06
- VAIDrug Quality Assurance2018-06-11
- VAIDrug Quality Assurance2016-07-12
- VAIDrug Quality Assurance2014-06-24
Drugs this plant is listed as making
2 distinct drugs across 4 products name this site in their FDA label.
- Irinotecan HydrochlorideIpsen Biopharmaceuticals, Inc.
- lanreotide acetateIpsen Biopharmaceuticals, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.